# Mativ Holdings, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Mativ Holdings, Inc.). ## Overview Mativ Holdings, Inc. is a U.S.-based specialty materials manufacturer that turns fibers, resins, chemicals and polymers into engineered media used to connect, protect and purify products and processes. It serves both business-to-business and consumer channels through global brands, with products spanning filtration, healthcare, advanced films, specialty papers, packaging and netting. ## Products & services • Specialty papers and packaging materials • Filtration media and netting products • Advanced films for protection and medical uses • Healthcare and wound care materials • Adhesive-coated and converted engineered media - **Filtration & Netting** (34%) — Specialty filtration media, components and extruded mesh used in air, liquid, industrial and agricultural applications. - **Advanced Films** (17%) — Thermoplastic polyurethane films and related materials used in protection, medical and security applications. - **Tape, Labels & Liners** (29%) — Engineered substrates and liners used in tapes, labels and other converting applications. - **Paper & Packaging** (20%) — Premium specialty papers and packaging materials for print, mail, retail and consumer uses. - Specialty papers for print, mail, graphics and education - Packaging materials for sustainable and premium applications - Filtration media for air, water, industrial and life science uses - Extruded mesh and netting for agriculture and packaging - Thermoplastic polyurethane films for protection and medical uses - Healthcare materials for wound care, fixation and medical packaging ## Customers Mativ sells to industrial, healthcare, packaging, converting and consumer-oriented customers that need highly engineered materials rather than commodity paper or film. Many products are customized and require qualification, so customers value performance, reliability and supply continuity more than low price alone. - **Industrial filtration and purification customers** (primary) — Buy filtration media and netting for air, water, industrial and life science applications because performance and qualification matter. - **Healthcare and medical device customers** (primary) — Buy wound care, fixation, medical packaging and medical film materials that must meet strict performance standards. - **Tape, label and converting customers** (primary) — Buy liners and engineered substrates used in adhesive systems, labels and other converting applications. - **Paper and packaging customers** (secondary) — Buy premium specialty papers and packaging materials for print, mail, graphics and sustainable packaging uses. - **Consumer and retail channels** (secondary) — Buy office, stationery and craft papers for resale to small business, personal and educational users. - System integrators and downstream manufacturers buying component materials - Healthcare customers needing wound care, fixation and medical packaging - Packaging and converting customers seeking specialty substrates and liners - Industrial and filtration customers needing separation and purification media - Retail and consumer channels buying office, stationery and craft papers ## Geography Mativ manufactures on three continents and sells in more than 100 countries, with the business most concentrated in North America and Europe. Its global footprint supports local customer service and supply reliability, while also exposing the company to tariffs, foreign exchange and cross-border trade disruption. - **North America** (50%) — Management says sales are most prevalent in North America. - **Europe** (35%) — Management says sales are most prevalent in Europe. - **Asia-Pacific** (10%) — Smaller but meaningful market according to management. - **Rest of World** (5%) — Residual global markets not separately disclosed. - Manufacturing footprint spans 34 production locations worldwide - Sales are most concentrated in North America and Europe - Asia-Pacific and rest of world are smaller but meaningful markets - Global supply chain supports local delivery and customer qualification - Cross-border trade exposure increases tariff and FX sensitivity ## Strategy Mativ is repositioning its portfolio toward higher-growth, higher-value specialty materials where customer qualification and technical performance create switching costs. The company is also using its global manufacturing base, R&D and converting capabilities to deepen relationships in filtration, healthcare and other preferred categories. - **Portfolio shift to preferred categories** (medium-term) — Management wants more exposure to higher-growth end markets and less reliance on slower or more cyclical applications. - **Innovation and product development** (medium-term) — Customized, high-performance products support pricing power and customer retention. - **Global supply chain and local service** (short-term) — A broad manufacturing footprint helps meet customer qualification, delivery and regulatory needs. - Shift portfolio toward higher-growth specialty materials - Use R&D to improve product performance and customer-specific solutions - Leverage global manufacturing to serve customers locally - Expand in filtration, healthcare and other preferred categories - Protect margins through innovation, quality and customer qualification ## Risks Mativ faces cyclical demand, customer destocking, tariff and trade uncertainty, and foreign exchange exposure because it sells engineered materials globally into industrial and consumer end markets. Company-specific risks also include integration and restructuring execution, debt covenant pressure and goodwill impairment risk tied to weaker end-market conditions. - **Tariffs and trade retaliation** [high] — The company sources and sells across borders, so tariff changes can raise input costs and disrupt customer pricing. - **Cyclical end-market demand** [high] — Many products serve markets affected by economic cycles, inventory destocking and customer downtime. - **Debt and covenant pressure** [high] — High leverage reduces flexibility and creates refinancing and covenant compliance risk. - **Goodwill impairment** [high] — Weak share price, lower cash flow expectations or higher discount rates can trigger non-cash charges. - **Integration and restructuring execution** [medium] — Acquisitions and restructuring can disrupt operations and fail to deliver expected synergies. - Demand is cyclical and tied to industrial and consumer end markets - Tariffs and trade actions can raise costs and disrupt supply chains - Foreign exchange moves affect reported results and competitiveness - Debt levels and covenant compliance limit financial flexibility - Goodwill impairment risk remains elevated after 2025 charges - Integration and restructuring can disrupt operations and expected synergies ## Accounting The most important accounting issue is goodwill impairment, which can create large non-cash charges when forecasts or discount rates change; Mativ recorded a $411.9 million impairment in 2025 for the FAM reporting unit. Investors should also watch seasonality, restructuring charges, and the effects of debt and lease accounting on reported leverage and earnings comparability. - **Goodwill impairment testing** — 2025 FAM impairment of $411.9 million - **Seasonality and downtime** — Quarterly revenue and margin volatility - **Restructuring and integration costs** — Comparability of adjusted and reported earnings - **Debt and covenant accounting** — Liquidity and going-concern style monitoring - Goodwill impairment can create large non-cash charges - Forecast assumptions and discount rates drive valuation tests - Seasonality affects quarterly sales and machine downtime - Restructuring charges can distort operating comparability - Debt and lease obligations affect leverage and cash flow presentation --- *Last updated: 2026-04-28T20:26:34.379697+00:00*